Drug Type Small molecule drug |
Synonyms FHND6091 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plasma cell myeloma refractory | Phase 1 | CN | 22 Dec 2021 | |
Relapse multiple myeloma | Phase 1 | CN | 03 Sep 2021 | |
Solid tumor | IND Approval | CN | 06 Mar 2024 |